24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Pfizer
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
22:27
Five months old, Noetive raises $41 million Seed to build AI for the physical economy
20:39
The man who helped build Palo Alto’s Cortex is leaving the company
20:20
Wiz founders Rappaport and Costica add television to their post-exit portfolio with $120 million Reshet 13 deal
17:12
Israel’s tech exports hit a record but foreign owners are claiming more of the gains
More stories
Buzz
Most popular
Daily
Weekly
1
How an Israeli engineer went from Rafael to iPhone Portrait Mode and a $300 million OpenAI exit
2
Oracle is expanding layoffs but its new CFO says “don’t do more with less”
3
The ThinkPad X13 is almost boring, and that’s exactly the point
4
Buildots raises $130 million at nearly $1 billion valuation as AI boom drives data center construction
5
Former Mossad chief Yossi Cohen joins Israeli quantum tech company Quantum X Labs
More news
Pfizer
11 stories about Pfizer
First Pfizer Covid-19 vaccines land in Israel, Netanyahu plans to be first to receive it
09.12.20
|
Reuters
Israel plans to start administering the doses on Dec. 20, distributor Teva Pharmaceutical Industries said
Mega-cap tech firms could lag the market next year, but tech in general won't underperform, says UBS chief investment officer
06.12.20
|
Sophie Shulman
Mark Haefele, Chief Investment Officer at UBS Global Wealth Management, says that stock markets will rise and fall depending on how quickly Covid-19 vaccines are approved and distributed
“Excessive regulation” to blame for delay in Israeli Covid-19 vaccine says professor in charge
30.11.20
|
CTech
Director of the Israel Institute for Biological Research says vaccines will be distributed in the summer of 2021
New innovative vaccines by Moderna and Pfizer are safe, says top Israeli virologist
24.11.20
|
Yafit Ovadia
“There isn’t any need for alarm,” says virologist about new coronavirus vaccines
After a coronavirus vaccine is approved, what happens next?
22.11.20
|
Sophie Shulman
On Dec. 10, the FDA is expected to announce whether it will approve Pfizer’s new vaccine, but 2 trillion people will not receive it until the end of 2021
Markets may recover from pandemic soon, says CapitalG investor
17.11.20
|
CTech
Vaccine announcements, possible removal of U.S. travel ban and other factors will contribute to economic recovery, senior investors say in Calcalist and CTech’s Mind the Tech virtual conference
Moderna’s chief scientist says company initiated vaccine deal with Israel
16.11.20
|
Sophie Shulman
Israeli scientist Tal Zaks says Israel will be among the first to receive doses from the company’s European plant
Pfizer and BioNTech claim 90% effective rate for their Covid-19 vaccine
09.11.20
|
Reuters
The news comes at the same time that Israel is currently undergoing human trials of its own vaccine for deployment in 2021
As the Covid-19 vaccine arms race intensifies, big money is at risk
10.08.20
|
Sophie Shulman
Governments want to be among the first to get their hands on the coveted solution, but they are also risking money that could be used to strengthen their healthcare system
Place your bets: Which company will reach a Covid-19 vaccine first?
02.08.20
|
Sophie Shulman
Moderna may be creating all the buzz, but it is the youngest and least experienced of the contestants, playing an all or nothing game
Pfizer Taps Israeli Machine Learning Drug Discovery Company CytoReason
10.01.19
|
Lilach Baumer
Under the agreement, CytoReason will receive payments "potentially equaling up to low double digit millions" of dollars
Previous Articles